Typically, cancer cells secrete various proangiogenic factors such as vascular endothelial growth factors (VEGFs), fibroblast growth factor-2 (FGF-2), and transforming growth factor-alpha (TGF-α), which can activate proangiogenic signalling pathways to promote tumor growth, invasion, metastasis, and angiogenesis [4]. The gene discussed is FGF2; the disease is neoplasm.